Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI creates 3D gum disease maps to guide dental surgery

NCT ID NCT07505251

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an artificial intelligence system called PerioAI V2.0 that creates a detailed 3D map of gum disease from dental scans. Researchers will enroll 80 adults with moderate-to-severe periodontitis who need gum surgery. The AI's map will be compared to what surgeons see during the actual surgery to see if it accurately identifies bone defects and helps plan treatment. If it works, this tool could make gum surgery more precise and less reliant on a dentist's experience alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PerioAI V2.0 software (artificial intelligence diagnostic tool)
What this could lead to
If successful, this AI tool could help dentists see gum disease in 3D before surgery, leading to more accurate treatment plans and better outcomes.
What could go wrong
This is an early-stage study with only 80 participants, so results may not apply to everyone. The AI's accuracy depends on scan quality and may not outperform standard exams.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient diagnosed with Stage II-IV periodontitis and has at least one tooth requiring periodontal surgery

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged ≥ 18 years. 2. Diagnosed with Stage II-IV periodontitis according to the 2018 Classification of Periodontal Diseases. 3. Presence of at least one tooth requiring periodontal surgery (including open flap debridement or regenerative surgery) due to periodontitis, where the intra-bony defect can be exposed intra-operatively for measurement. 4. Voluntary participation and provision of written informed consent. Exclusion Criteria: 1. Pregnant or lactating women. 2. Presence of uncontrolled systemic diseases that significantly affect surgery or tissue healing, such as uncontrolled diabetes mellitus or immunodeficiency. 3. History of head and neck radiotherapy. 4. Inability to cooperate with the required study examinations.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Periodontitis stage II are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.